102 related articles for article (PubMed ID: 9296366)
1. Specific inhibition of human CYP1A2 using a targeted antibody.
Adams DA; Edwards RJ; Davies DS; Boobis AR
Biochem Pharmacol; 1997 Jul; 54(1):189-97. PubMed ID: 9296366
[TBL] [Abstract][Full Text] [Related]
2. Identification of the epitope of an anti-peptide antibody which binds to CYP1A2 in many species including man.
Edwards RJ; Murray BP; Singleton AM; Murray S; Davies DS; Boobis AR
Biochem Pharmacol; 1993 Jul; 46(2):213-20. PubMed ID: 7688509
[TBL] [Abstract][Full Text] [Related]
3. An inhibitory monoclonal anti-protein antibody and an anti-peptide antibody share an epitope on rat cytochrome P-450 enzymes CYP1A1 and CYP1A2.
Edwards RJ; Murray BP; Murray S; Singleton AM; Davies DS; Boobis AR
Biochim Biophys Acta; 1993 Jan; 1161(1):38-46. PubMed ID: 7678502
[TBL] [Abstract][Full Text] [Related]
4. Human hepatic CYP1A1 and CYP1A2 content, determined with specific anti-peptide antibodies, correlates with the mutagenic activation of PhIP.
Murray BP; Edwards RJ; Murray S; Singleton AM; Davies DS; Boobis AR
Carcinogenesis; 1993 Apr; 14(4):585-92. PubMed ID: 8472319
[TBL] [Abstract][Full Text] [Related]
5. Short synthetic peptides exploited for reliable and specific targeting of antibodies to the C-termini of cytochrome P450 enzymes.
Edwards RJ; Singleton AM; Murray BP; Davies DS; Boobis AR
Biochem Pharmacol; 1995 Jan; 49(1):39-47. PubMed ID: 7840781
[TBL] [Abstract][Full Text] [Related]
6. Affinity and potency of proinhibitory antipeptide antibodies against CYP2D6 is enhanced using cyclic peptides as immunogens.
Schulz-Utermoehl T; Edwards RJ; Boobis AR
Drug Metab Dispos; 2000 May; 28(5):544-51. PubMed ID: 10772633
[TBL] [Abstract][Full Text] [Related]
7. Development of a comprehensive panel of antibodies against the major xenobiotic metabolising forms of cytochrome P450 in humans.
Edwards RJ; Adams DA; Watts PS; Davies DS; Boobis AR
Biochem Pharmacol; 1998 Aug; 56(3):377-87. PubMed ID: 9744576
[TBL] [Abstract][Full Text] [Related]
8. Identification of a functionally conserved surface region of rat cytochromes P450IA.
Edwards RJ; Singleton AM; Murray BP; Murray S; Boobis AR; Davies DS
Biochem J; 1991 Sep; 278 ( Pt 3)(Pt 3):749-57. PubMed ID: 1716884
[TBL] [Abstract][Full Text] [Related]
9. Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human.
Edwards RJ; Murray BP; Murray S; Schulz T; Neubert D; Gant TW; Thorgeirsson SS; Boobis AR; Davies DS
Carcinogenesis; 1994 May; 15(5):829-36. PubMed ID: 8200083
[TBL] [Abstract][Full Text] [Related]
10. Selective and potent inhibition of human CYP2C19 activity by a conformationally targeted antipeptide antibody.
Schulz-Utermoehl T; Mountfield RJ; Madsen K; Jørgensen PN; Hansen KT
Drug Metab Dispos; 2000 Jul; 28(7):715-7. PubMed ID: 10859141
[TBL] [Abstract][Full Text] [Related]
11. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
Tassaneeyakul W; Birkett DJ; Veronese ME; McManus ME; Tukey RH; Quattrochi LC; Gelboin HV; Miners JO
J Pharmacol Exp Ther; 1993 Apr; 265(1):401-7. PubMed ID: 8474022
[TBL] [Abstract][Full Text] [Related]
12. Molecular cloning and functional analysis of cytochrome P450 1A2 from Japanese monkey liver: comparison with marmoset cytochrome P450 1A2.
Narimatsu S; Oda M; Hichiya H; Isobe T; Asaoka K; Hanioka N; Yamano S; Shinoda S; Yamamoto S
Chem Biol Interact; 2005 Feb; 152(1):1-12. PubMed ID: 15766918
[TBL] [Abstract][Full Text] [Related]
13. Identification of cytochrome P450 1A2 as enzyme involved in the microsomal metabolism of Huperzine A.
Ma X; Wang H; Xin J; Zhang T; Tu Z
Eur J Pharmacol; 2003 Feb; 461(2-3):89-92. PubMed ID: 12586202
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase.
Masubuchi Y; Hosokawa S; Horie T; Suzuki T; Ohmori S; Kitada M; Narimatsu S
Drug Metab Dispos; 1994; 22(6):909-15. PubMed ID: 7895609
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.
Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT
Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105
[TBL] [Abstract][Full Text] [Related]
16. Inducibility of cytochromes P-450 by dioxin in liver and extrahepatic tissues of the marmoset monkey (Callithrix jacchus).
Schulz TG; Neubert D; Davies DS; Edwards RJ
Biochim Biophys Acta; 1996 Nov; 1298(1):131-40. PubMed ID: 8948497
[TBL] [Abstract][Full Text] [Related]
17. A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes.
Turpeinen M; Hofmann U; Klein K; Mürdter T; Schwab M; Zanger UM
Drug Metab Dispos; 2009 May; 37(5):1017-24. PubMed ID: 19204080
[TBL] [Abstract][Full Text] [Related]
18. Enzyme-kinetic and immunochemical characteristics of mouse cDNA-expressed, microsomal, and purified CYP1A1 and CYP1A2.
Tsyrlov IB; Goldfarb IS; Gelboin HV
Arch Biochem Biophys; 1993 Dec; 307(2):259-66. PubMed ID: 8274012
[TBL] [Abstract][Full Text] [Related]
19. An anti-peptide antibody targeted to a specific region of rat cytochrome P-450IA2 inhibits enzyme activity.
Edwards RJ; Singleton AM; Murray BP; Sesardic D; Rich KJ; Davies DS; Boobis AR
Biochem J; 1990 Mar; 266(2):497-504. PubMed ID: 1690539
[TBL] [Abstract][Full Text] [Related]
20. [O-ethyl 14C]phenacetin O-deethylase activity in human liver microsomes.
Rodrigues AD; Surber BW; Yao Y; Wong SL; Roberts EM
Drug Metab Dispos; 1997 Sep; 25(9):1097-100. PubMed ID: 9311627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
